Company intelligence / Profile preview

Frost Image

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Frost Biotherapeutics is a biotechnology company focused on developing next-generation therapies for oncology and autoimmune diseases. The company utilizes its proprietary Frost Platform to identify and optimize novel drug candidates with improved efficacy and safety profiles. By leveraging advanced imaging and computational biology, Frost Biotherapeutics aims to address significant unmet medical needs in complex disease areas. The company's pipeline includes several pre-clinical programs targeting key pathways in cancer progression and immune regulation.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeAntibody
Industry: Biotech

Beyond the preview

Go deeper on Frost Image.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frost Image.

Explore the full profile